Anne Gramkow

Senior Director, QPPV at Incyte
Anne Gramkow

Medical Doctor by training, worked within pharmaceutical industry since 1999 within the pharmacovigilance area – both within clinical and post-marketing safety.
Has been heading a Drug Safety department and acted EU-QQPV for a Danish pharmaceutical company for the past 6 years.
Recently joined the American biotech company Incyte as Senior Director and EU-QPPV. Has been responsible for setting up both clinical and post-marketing pharmacovigilance systems, including handling of Safety Data Exchange Agreement (SEDEAs).

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more